DiAGSure® Crimean-Congo Haemorrhegic Fever Detection Kit

Catalog No.: GDQ6013-50R, GDQ6013-100R
Intent to use:
The DiAGSure® Crimean-Congo Haemorrhagic Fever (CCHF) Detection Kit is a highly sensitive and specific real-time PCR assay designed for the rapid detection of CCHF virus (CCHFV), a deadly tick-borne pathogen causing severe viral hemorrhagic fever. Transmitted through the bite of infected Hyalomma ticks or direct contact with infected blood or tissues, CCHF poses a serious public health threat, especially to livestock handlers, healthcare workers, and people in endemic regions. The disease has a high case fatality rate and presents with sudden onset of fever, myalgia, and bleeding manifestations. Early and accurate detection is critical to prevent nosocomial transmission, initiate supportive care, and implement containment measures. The DiAGSure® kit targets conserved genomic regions of CCHFV, enabling reliable detection even in early infection stages. It is a vital diagnostic tool for clinical management, outbreak control, and biosafety monitoring in high-risk environments.

Key Specifications:
 Real-time PCR-based detection of CCHFV enables prompt and reliable identification of Crimean-Congo haemorrhagic fever.
 Designed for early-stage diagnosis, helping reduce fatality rates in high-risk populations.
 Delivers high diagnostic accuracy, even in samples with low viral loads or during early infection.
 Essential for containment and biosafety, particularly in hospitals, labs, and animal-handling environments.
 Easily deployable on widely used qPCR instruments, streamlining use in clinical and public health settings.

 Sample types:
Whole Blood, EDTA Plasma, Respiratory Swabs in VTM, Tissue.

Product information: